Sencilia raises about €2 million in NOM-led funding round

• Sencilia, a Groningen-based medical technology startup, raised approximately €2 million in a financing round led by NOM.
• Other investors included Future Tech Ventures, imec.istart and a group of institutional and private investors.
• The financing also includes a grant through Europe's Eureka Eurostars program and an innovation loan from Rabobank.
• Sencilia's Rely-V sensor monitors intravenous medication flow, initially targeting safer treatment for babies and children.
• Proceeds will support production readiness, clinical data collection and partnerships with infusion pump and infusion set manufacturers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NV NOM published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.